These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 4802109)

  • 1. Psychosomatic grand rounds: Graves' disease.
    Jacobs S
    Psychosomatics; 1973; 14(5):259-65. PubMed ID: 4802109
    [No Abstract]   [Full Text] [Related]  

  • 2. The outcome of 131I treatment in Graves' patients pretreated or not with methimazole.
    Pirnat E; Zaletel K; Gaberšček S; Hojker S
    Hell J Nucl Med; 2011; 14(1):25-9. PubMed ID: 21512661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis and management of Graves' disease.
    Ginsberg J
    CMAJ; 2003 Mar; 168(5):575-85. PubMed ID: 12615754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No prognostic value of thyroid autoantibodies changes during and after methimazole therapy in patients with Graves' disease.
    Lattanzi V; Ciampolillo A; Vincenti C; Giorgino R
    Boll Soc Ital Biol Sper; 1985 Apr; 61(4):507-13. PubMed ID: 3840026
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
    Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
    N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of methimazole and radioactive iodine treatment in the serum levels of the chemokine CXCL10 in hyperthyroid patients with Graves' disease.
    Leite AC; Pedro AB; Romaldini JH
    Horm Metab Res; 2011 Mar; 43(3):194-9. PubMed ID: 21283953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
    Izumi M; Larsen PR
    J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group.
    Tallstedt L; Lundell G; Tørring O; Wallin G; Ljunggren JG; Blomgren H; Taube A
    N Engl J Med; 1992 Jun; 326(26):1733-8. PubMed ID: 1489388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing the relationship between labelled triiodothyronine and thyroxine levels in the serum of patients with Graves' disease.
    Földes J; Gyertyánfy G; Tako J; Bános C; Gesztesi E
    Endokrinologie; 1973 Jan; 61(1):52-64. PubMed ID: 4739850
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid control of thyrotoxicosis with combined 131I, anthithyroid drugs and KI therapy.
    Refetoff S; Demeester-Mirkine N; Ermans AM; DeGroot LJ
    J Nucl Med Allied Sci; 1977; 21(1-2):23-9. PubMed ID: 578811
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.
    Pedro AB; Romaldini JH; Takei K
    Neuroimmunomodulation; 2011; 18(1):45-51. PubMed ID: 20628263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of Graves-Basedow disease].
    Angel M
    Med Clin (Barc); 1988 May; 90(18):748-54. PubMed ID: 2902259
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyrotoxicosis in pregnancy.
    Emerson CH
    Curr Ther Endocrinol Metab; 1994; 5():275-7. PubMed ID: 7704731
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

  • 18. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC; Di Martino F; Grosso M; Monzani F; Dardano A; Caraccio N; Mariani G; Lazzeri M
    Phys Med Biol; 2005 May; 50(9):2181-91. PubMed ID: 15843745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of Graves' disease to low dose methimazole.
    Elias AN
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):243. PubMed ID: 8849582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.